🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 110 of 200 · A–Z by INN

  1. lifitegrast

    XIIDRA

    OPHTHALMIC FDA: approved · EMA: application withdrawn

    S01XA25

  2. light liquid paraffin + cocoamphodiacetate disodium

    HAMILTON SKIN THERAPY WASH Lacuna Pharma Pty Ltd

    TGA: approved

  3. linaclotide

    CONSTELLA

    ORAL FDA: approved · EMA: approved · NMPA: clinical trials

    A06AX04

  4. linagliptin

    TRAJENTA Boehringer Ingelheim Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    A10BD11

  5. linagliptin + metformin

    TRAJENTAMET Boehringer Ingelheim Pty Ltd

    TGA: approved

  6. linagliptin and metformin hydrochloride

    LINAGLIPTIN AND METFORMIN HYDROCHLORIDE

    ORAL FDA: approved

  7. lincomycin

    LINCOMYCIN SXP Pfizer Australia Pty Ltd

    TGA: approved

  8. lincomycin hydrochloride

    LINCOMYCIN HCL

    INJECTION FDA: approved

  9. linctuses containing codeine phosphate

    NULL

    TGA: approved

  10. linctuses, other

    NULL

    TGA: approved

  11. lindane

    GAMENE

    TOPICAL FDA: approved

  12. linerixibat

    LYNAVOY

    ORAL FDA: approved

  13. linezolid

    LINEZOLID Amneal Pharma Europe Ltd

    ORAL FDA: approved

  14. linvoseltamab

    LYNOZYFIC Regeneron UK Limited

    EMA: approved

    L01FX

  15. linvoseltamab-gcpt

    LYNOZYFIC Shanghai Antengene Corporation Limited

    INJECTION FDA: approved

  16. linzagolix choline

    YSELTY

    EMA: approved

    H01CC04

  17. liothyronine

    TERTROXIN Lacuna Pharma Pty Ltd

    TGA: approved

  18. liothyronine sodium

    TRIOSTAT Teva Pharma GmbH

    INJECTION FDA: approved

  19. liotrix (t4

    EUTHROID-2

    ORAL FDA: approved

  20. lipegfilgrastim

    LONQUEX Lacuna Pharma Pty Ltd

    EMA: approved · TGA: approved

    L03AA14

  21. lipotecan

    NMPA: clinical trials

  22. liquid paraffin + glycerol + tyloxapol + poloxamer-188 + trometamol hydrochloride + trometamol + cetalkonium chloride

    CATIONORM Seqirus (Australia) Pty Ltd

    TGA: approved

  23. liquorice liquid extract

    NULL

    TGA: approved

  24. liraglutide

    SAXENDA Teva Pharma GmbH

    SUBCUTANEOUS FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    A10BJ02

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources